These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 3319347)

  • 1. Clinical pharmacokinetics of D-penicillamine.
    Netter P; Bannwarth B; Péré P; Nicolas A
    Clin Pharmacokinet; 1987 Nov; 13(5):317-33. PubMed ID: 3319347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of slow-acting antirheumatic drugs.
    Tett SE
    Clin Pharmacokinet; 1993 Nov; 25(5):392-407. PubMed ID: 7904547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacology and mechanism of action of D-penicillamine in rheumatoid polyarthritis].
    Clerc D; Sallière D; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1983 May; 50(6):457-63. PubMed ID: 6351235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of albumin conjugates of D-penicillamine in humans.
    Joyce DA; Day RO; Murphy BR
    Drug Metab Dispos; 1991; 19(2):309-11. PubMed ID: 1676628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of homocysteine, penicillamine, and their symmetrical and mixed disulfides by liquid chromatography with electrochemical detection.
    Rabenstein DL; Yamashita GT
    Anal Biochem; 1989 Aug; 180(2):259-63. PubMed ID: 2817354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of factors limiting the accurate measurement of plasma D-penicillamine in rheumatoid arthritis patients.
    Webb BA; Richardson SJ; Haslock I
    Ann Clin Biochem; 1988 Mar; 25 ( Pt 2)():186-91. PubMed ID: 3382150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel HPLC-electrochemical detection approach for the determination of D-penicillamine in skin specimens.
    Saracino MA; Cannistraci C; Bugamelli F; Morganti E; Neri I; Balestri R; Patrizi A; Raggi MA
    Talanta; 2013 Jan; 103():355-60. PubMed ID: 23200399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.
    Joyce DA; Day RO
    Br J Clin Pharmacol; 1990 Oct; 30(4):511-7. PubMed ID: 2291865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay for D-penicillamine-protein conjugate in human plasma utilising chemical reduction followed by high-performance liquid chromatography with gold/mercury electrochemical detection.
    Joyce DA; Wade DN
    J Chromatogr; 1988 Sep; 430(2):319-27. PubMed ID: 3235506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of penicillamine, penicillamine disulfide and penicillamine-glutathione mixed disulfide by high-performance liquid chromatography with electrochemical detection.
    Yamashita GT; Rabenstein DL
    J Chromatogr; 1989 Jul; 491(2):341-54. PubMed ID: 2808620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
    Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
    Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in oral penicillamine absorption by food, antacid, and ferrous sulfate.
    Osman MA; Patel RB; Schuna A; Sundstrom WR; Welling PG
    Clin Pharmacol Ther; 1983 Apr; 33(4):465-70. PubMed ID: 6831825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and relative bioavailability of D-penicillamine in fasted and nonfasted dogs.
    Langlois DK; Lehner AF; Buchweitz JP; Ross DE; Johnson MB; Kruger JM; Bailie MB; Hauptman JG; Schall WD
    J Vet Intern Med; 2013; 27(5):1071-6. PubMed ID: 23875792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of D-penicillamine in man.
    Wiesner RH; Dickson ER; Carlson GL; McPhaul LW; Go VL
    J Rheumatol Suppl; 1981; 7():51-5. PubMed ID: 6939886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis.
    Carruthers G; Harth M; Freeman D; Weir D; Rothwell R; Butler M
    Clin Invest Med; 1984; 7(1):35-40. PubMed ID: 6723122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determination of D-penicillamine and its disulphide in plasma by reversed-phase ion-pair high-performance liquid chromatography.
    Abounassif MA; Jefferies TM
    J Pharm Biomed Anal; 1983; 1(1):65-72. PubMed ID: 16867835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for assaying D-penicillamine in a clinical setting.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):31-4. PubMed ID: 6723121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
    Willhite CC; Ball GL; McLellan CJ
    Crit Rev Toxicol; 2012 May; 42(5):358-442. PubMed ID: 22512666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.